Parkman Healthcare Partners’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-127,812
Closed -$1.88M 95
2024
Q3
$1.88M Buy
127,812
+1,770
+1% +$24.7K 0.24% 76
2024
Q2
$1.82M Sell
126,042
-75,139
-37% -$1.2M 0.24% 75
2024
Q1
$3.28M Buy
+201,181
New +$3.15M 0.4% 70

Other funds holding ELAN

Parkman Healthcare Partners's ELAN Position: Q4 2024 in Review

Parkman Healthcare Partners sold out of Elanco Animal Health (ELAN) in Q4 2024, closing a stake of 127,812 shares — an estimated $1.88M sold.

Parkman Healthcare Partners first reported a position in ELAN in Q1 2024 and held it in 3 quarters. The position peaked at $3.28M in Q1 2024. 393 funds tracked by Wall St. Rank hold ELAN as of Q4 2024.

  • Parkman Healthcare Partners reported no remaining Elanco Animal Health position as of Q4 2024 after selling out during the quarter.
  • Parkman Healthcare Partners sold 127,812 Elanco Animal Health shares in Q4 2024, an estimated $1.88M.
  • Parkman Healthcare Partners first reported a position in Elanco Animal Health in Q1 2024 and held it in 3 quarters.
  • Parkman Healthcare Partners's Elanco Animal Health position peaked at $3.28M in Q1 2024.
  • 393 funds tracked by Wall St. Rank held Elanco Animal Health as of Q4 2024.

Based on Parkman Healthcare Partners's 13F filing for Q4 2024, filed 14 Feb 2025.